Whitehawk Therapeutics, Inc. (WHWK)
4.70
-0.40
(-7.84%)
USD |
NASDAQ |
May 15, 16:00
4.68
-0.02
(-0.43%)
After-Hours: 20:00
Whitehawk Therapeutics Shareholders Equity (Quarterly) : 116.18M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 107.41M |
| Replimune Group, Inc. | 210.54M |
| Lantern Pharma, Inc. | 3.446M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.23M |
| Total Liabilities (Quarterly) | 11.06M |
| Current Ratio | 11.36 |
| Net Debt Paydown Yield | 0.10% |